Insmed (INSM) Other Accumulated Expenses (2011 - 2024)
Insmed (INSM) recorded quarterly Other Accumulated Expenses of $8.5 million in Q3 2024, down 1.41% quarter-over-quarter from $8.6 million in Q2 2024, and up 283.71% on a YoY basis from $2.2 million in Q4 2023.
Insmed (INSM) Other Accumulated Expenses (2011 - 2024) Analysis & Trends
Insmed's Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $8.5 million for Q3 2024.
- In Q3 2024, Other Accumulated Expenses rose 283.71% year-over-year to $8.5 million; the TTM figure through Sep 2024 stood at $8.5 million (up 283.71% YoY), while the FY2023 annual figure was $10.4 million, up 549.12% from the prior year.
- Other Accumulated Expenses was $8.5 million for Q3 2024 at Insmed, down from $8.6 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $10.4 million in Q4 2023 to a low of $78000.0 in Q1 2020.
- Historically, Other Accumulated Expenses has averaged $4.9 million across 5 years, with a median of $2.4 million in 2021.
- Biggest YoY gain for Other Accumulated Expenses was 549.12% in 2023; the steepest drop was 58.24% in 2023.
- A 5-year view of Other Accumulated Expenses shows it stood at $78000.0 in 2020, then jumped by 2979.49% to $2.4 million in 2021, then sank by 33.56% to $1.6 million in 2022, then jumped by 549.12% to $10.4 million in 2023, then retreated by 17.7% to $8.5 million in 2024.
- The last three Other Accumulated Expenses figures came in at $8.5 million (Q3 2024), $8.6 million (Q2 2024), and $10.2 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 8.53 Mn |
| Jun 30, 2024 | 8.65 Mn |
| Mar 31, 2024 | 10.21 Mn |
| Dec 31, 2023 | 10.36 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 5.32 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 280,000.00 |
| Sep 30, 2019 | 130,000.00 |
| Jun 30, 2019 | 234,000.00 |
| Mar 31, 2019 | 82,000.00 |
| Dec 31, 2018 | 1.53 Mn |
| Sep 30, 2018 | 472,000.00 |
| Jun 30, 2018 | 630,000.00 |
| Mar 31, 2018 | 556,000.00 |
| Dec 31, 2017 | 646,000.00 |